Clinical TrialsSearch results
Number of results: 693
Other
- A randomized phase II (/III) study of TXT/TS-1 (DS) combination vs CDDP/5-FU therapy (FUP) in metastatic gastric cancer
- Chemotherapy-naïve metastatic gastric cancer
- Hiroshima Cancer Therapy Development Organization (HiCTDO)
- 2005-10-01
Other
- Pharmacogenomic Study for Individual Response to CPT-11 in Colorectal Cancer Patients (Step 2)
- Stage IV colorectal cancer after palliative operation
- Hiroshima Cancer Therapy Development Organization (HiCTDO)
- 2005-10-01
Other
- Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer
- Metastatic gastric cancer (Advanced or recurrent gastric cancer)
- Hiroshima Cancer Therapy Development Organization (HiCTDO)
- 2005-10-01
Other
- Phase II, multicenter, open-label study of Trastuzumab derxtecan in patients with HER2-expressing recurrent and or metastatic salivary gland carcinoma
- HER2-expressing recurrent and/or metastatic salivary gland carcinoma
- Hirotoshi Akita
- 2021-06-17
Recruiting
- Intravenous infusion of autologous mesenchymal stem cells from bone marrow for ALS patients: double-blind randomized controlled trial
- Amyotrophic Lateral Sclerosis (ALS)
- HISAHARA SHIN
- 2020-03-04
Recruiting
- Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE (POETYK SLE-2)
- Systemic Lupus Erythematosus
- Hobar Coburn
- 2023-04-07
Recruiting
- Effect of remimazolam compared to propofol on blood pressure variability in the elderly
- Hypotension during general anesthesia induction
- Hojo Takayuki
- 2023-06-21
Other
- Phase 3 study of pembrolizumab vs chemotherapy in dMMR advanced or recurrent endometrial carcinoma
- Endometrial cancer
- Hoki Toshifumi
- 2022-01-30
Recruiting
- Belzutifan/MK-6482 for the treatment of PPGL or pNET or VHL disease
- Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, VHL Disease-Associated Tumors
- Hoki Toshifumi
- 2022-11-04
Other
- The clinical study on immunotherapy for advanced renal cell carcinoma =Combination therapy of natural IFN-alfa and meloxicam against metastatic renal cell crcinoma=
- metastatic renal cell carcinoma
- Hokkaido Advanced Renal Cell Carcinoma Treatment Group
- 2009-03-13